Polycystic ovary syndrome (PCOS) affects 10% of reproductive‐aged women, and is marked by irregular menses and high androgens. PCOS is a known risk factor for imaging‐confirmed steatosis, and we now… Click to show full abstract
Polycystic ovary syndrome (PCOS) affects 10% of reproductive‐aged women, and is marked by irregular menses and high androgens. PCOS is a known risk factor for imaging‐confirmed steatosis, and we now aim to evaluate whether PCOS influences histologic severity of non‐alcoholic fatty liver disease (NAFLD).
               
Click one of the above tabs to view related content.